Somnics participated in Medical Fair Asia 2026, showcasing its independently developed iNAP® oral negative pressure therapy system for obstructive sleep apnea to the global market and continuing to advance the international reach of Taiwan’s sleep medicine technology.

Somnics announced that the company has received Korea Medical Device Registration and Approval（KFDA）for iNAP® One Sleep Therapy System.